Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy
Related Experiment Video
Updated: Mar 8, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Yuqing Zhou1, Qian Dong2, Rong Zhang3
1Department of Gastroenterology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China; The School of Medicine of Soochow University, Suzhou 215006, China.
Insights
Cerebral hemodynamics are impaired in patients with cirrhosis and hepatic encephalopathy (HE). Treatment with lactulose improved cerebral blood flow and cognitive function, showing a link between ammonia levels and brain function.
Area of Science:
- Neurology
- Hepatology
- Medical Imaging
Background:
- Hepatic encephalopathy (HE) is a neurological complication of liver cirrhosis.
- Cerebral hemodynamics and cognitive function are often impaired in patients with HE.
- The relationship between ammonia levels, cerebral hemodynamics, and cognitive function in HE requires further investigation.
Purpose of the Study:
- To investigate cerebral hemodynamics in cirrhotic patients with varying degrees of hepatic encephalopathy (HE).
- To assess the impact of lactulose treatment on cerebral hemodynamics and ammonia levels in patients with minimal hepatic encephalopathy (MHE).
- To explore correlations among ammonia, cerebral hemodynamics, and cognitive function in cirrhosis.
Main Methods:
- Four groups were studied: healthy controls, cirrhosis without HE, cirrhosis with MHE, and cirrhosis with overt HE (OHE).
- Cerebral hemodynamics were assessed using transcranial Doppler (TCD).
- Patients with MHE were randomized to receive lactulose treatment or placebo, with re-evaluation of ammonia and TCD parameters post-treatment.
Main Results:
- Pre-treatment, ammonia levels and cerebral hemodynamic parameters (Vmean, PI, RI) differed significantly across groups and correlated with HE severity.
- Lactulose treatment in MHE patients led to improved Vmean and reduced ammonia, PI, and RI levels.
- No significant changes were observed in the control group, and correlations were found between ammonia, cerebral hemodynamics, and cognitive tests (NCT-A, DST).
Conclusions:
- Cerebral hemodynamics are significantly related to the severity of hepatic encephalopathy.
- Cerebral autoregulation is impaired in cirrhotic patients with HE.
- Ammonia levels, cerebral hemodynamics, and cognitive function are closely interconnected, with treatment improving cerebral hemodynamics.
Abstract:
Aims. To investigate cerebral hemodynamics in cirrhotic patients with HE and to observe effects of treatment in cerebral hemodynamics and correlations among ammonia, cerebral hemodynamics, and cognitive function. Methods. There were four groups: healthy controls (group 1), cirrhosis without HE (group 2), cirrhosis with MHE (group 3), and cirrhosis with OHE (group 4). Ammonia and cerebral hemodynamics (by TCD) were assessed. Patients in group 3 were subsequently randomized to two subgroups: the control (group A) and the treated (group B, treated with lactulose for two months), and they were retested for ammonia and TCD after treatment.
Results:
Ammonia, V , V , PI, and RI were statistically different before treatment, and ammonia, PI, and RI levels paralleled the severity of HE (P < 0.05). In group B, V increased and ammonia, PI, and RI declined following treatment (P < 0.05), while there were no differences in group A (P > 0.05). Correlations were found between ammonia and V , PI, RI, NCT-A, and DST and also found between V , PI, RI, and NCT-A and DST (P < 0.05). Conclusions. This study revealed that cerebral hemodynamics were related to the severity of HE and cerebral autoregulation was impaired. There were tight correlations among ammonia, cerebral hemodynamics, and cognitive function, and, following treatment, cerebral hemodynamics improved.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cerebral Hemispheres

